University Hospital, Clermont-Ferrand: Metabolic Syndrome trials

The registry lists 11 Metabolic Syndrome studies with University Hospital, Clermont-Ferrand as lead sponsor. 1 are open to participants now and 0 have results posted.

No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of a New Optimized Plant Ingredient on the Plant Protein of Seniors at Cardio-metabolic RiskNot yet recruitingNCT06933589Not applicable
• Analysis of the Postprandial Effects of a Vegetable Protein Mixture Rich in Arginine, Cysteine and Leucine on Endothelial Dysfunction and Inflammation at Low Noise in Elderly People With Cardiometabolic RiskCompletedNCT04923555Not applicable
• Orange Juice, Hesperidin and Their Role in Vascular Health BenefitCompletedNCT04731987Not applicable
• Results at 10 Years of the RESOLVE Study (RESOLVE+10)Status unknownNCT04453098Not applicable
• Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics)CompletedNCT04236518Not applicable
• Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.Status unknownNCT03843905
• Effects of Polyphenols on Iron Absorption in Iron Overload Disorders.CompletedNCT03453918Not applicable
• CT Evaluation of Cardiovascular Risk Markers in Obese PatientsStatus unknownNCT03111693
• MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)Status unknownNCT02066012
• Development of Endothelial BiomarkersCompletedNCT02006810Not applicable
• Effect of Physical Activity and Diet on the Treatment of Metabolic SyndromeCompletedNCT00917917Not applicable